Christina Y. Weng, MD, MBA - Reimagining Retinal Treatment: The Promise of Novel Delivery Mechanisms for Anti-VEGF Therapies

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/COPE information, and to apply for credit, please visit us at PeerView.com/PVU865. CME/COPE credit will be available until April 26, 2027. Reimagining Retinal Treatment: The Promise of Novel Delivery Mechanisms for Anti-VEGF Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an educational grant from Genentech, a member of the Roche Group. Disclosure information is available at the beginning of the video presentation.

You can listen to Christina Y. Weng, MD, MBA - Reimagining Retinal Treatment: The Promise of Novel Delivery Mechanisms for Anti-VEGF Therapies online on Radio and Podcast. Open the player on this page to stream the available audio.

Christina Y. Weng, MD, MBA - Reimagining Retinal Treatment: The Promise of Novel Delivery Mechanisms for Anti-VEGF Therapies is an episode from PeerView Internal Medicine CME/CNE/CPE Audio Podcast by PeerView, 24 West 40th Street, Suite 950, New York, NY 10018.

This episode is 00:35:36 long.

This episode was published on May 12, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from PeerView Internal Medicine CME/CNE/CPE Audio Podcast when more episodes are available from the podcast feed.